Darren Barton

3.8k total citations · 2 hit papers
27 papers, 2.4k citations indexed

About

Darren Barton is a scholar working on Epidemiology, Surgery and Hepatology. According to data from OpenAlex, Darren Barton has authored 27 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 11 papers in Surgery and 9 papers in Hepatology. Recurrent topics in Darren Barton's work include Liver Disease Diagnosis and Treatment (14 papers), Liver Disease and Transplantation (5 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). Darren Barton is often cited by papers focused on Liver Disease Diagnosis and Treatment (14 papers), Liver Disease and Transplantation (5 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). Darren Barton collaborates with scholars based in United Kingdom, United States and Nigeria. Darren Barton's co-authors include Kathy Guo, Philip N. Newsome, Diana Hull, Matthew J. Armstrong, Jeremy Tomlinson, Stephen Gough, Jonathan Hazlehurst, Stefan G. Hübscher, Deborah Stocken and Rachel M. Brown and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Darren Barton

27 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study

2015 1.6k citations Matthew J. Armstrong, Piers Gaunt et al. The Lancet profile →
Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis

2015 351 citations Matthew J. Armstrong, Diana Hull et al. Journal of Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Darren Barton United Kingdom	14	1.7k	1.3k	669	619	466	27	2.4k
Mark Aldersley United Kingdom	13	1.5k 0.9×	1.1k 0.8×	569 0.9×	590 1.0×	349 0.7×	26	2.0k
Janet C. Shaw United States	7	1.9k 1.1×	855 0.6×	496 0.7×	825 1.3×	281 0.6×	9	2.4k
Piers Gaunt United Kingdom	11	1.4k 0.8×	1.1k 0.8×	373 0.6×	381 0.6×	392 0.8×	24	1.8k
Kittichai Promrat United States	16	2.4k 1.4×	1.1k 0.9×	340 0.5×	1.2k 1.9×	408 0.9×	34	2.8k
Abdullah Al‐Osaimi United States	21	1.8k 1.0×	552 0.4×	627 0.9×	1.2k 1.9×	266 0.6×	42	2.3k
Kristine Buchholtz Denmark	11	1.2k 0.7×	949 0.7×	381 0.6×	357 0.6×	314 0.7×	14	1.6k
Elizabeth E. Hespenheide United States	11	2.0k 1.2×	963 0.7×	443 0.7×	882 1.4×	327 0.7×	13	2.3k
Joel Z. Stengel United States	5	1.6k 0.9×	688 0.5×	299 0.4×	702 1.1×	211 0.5×	6	1.9k
Guillaume Lassailly France	16	1.7k 1.0×	699 0.5×	611 0.9×	753 1.2×	190 0.4×	47	2.1k
Luis Calzadilla Bertot Australia	16	3.2k 1.9×	1.5k 1.1×	564 0.8×	1.6k 2.6×	378 0.8×	38	3.6k

Countries citing papers authored by Darren Barton

Since Specialization

Citations

This map shows the geographic impact of Darren Barton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Darren Barton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Darren Barton more than expected).

Fields of papers citing papers by Darren Barton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Darren Barton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Darren Barton. The network helps show where Darren Barton may publish in the future.

Co-authorship network of co-authors of Darren Barton

This figure shows the co-authorship network connecting the top 25 collaborators of Darren Barton. A scholar is included among the top collaborators of Darren Barton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Darren Barton. Darren Barton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Homer, Victoria, Darren Barton, Kristian Brock, et al.. (2024). A low molecular weight dextran sulphate, ILB®, for the treatment of amyotrophic lateral sclerosis (ALS): An open-label, single-arm, single-centre, phase II trial. PLoS ONE. 19(7). e0291285–e0291285. 1 indexed citations

Mergental, Hynek, Richard W. Laing, Amanda Kirkham, et al.. (2023). Discarded livers tested by normothermic machine perfusion in the VITTAL trial: Secondary end points and 5-year outcomes. Liver Transplantation. 30(1). 30–45. 16 indexed citations

Casey, Anna, et al.. (2023). Efficacy and optimal dose of acetic acid to treat colonised burns wounds: protocol for a pilot randomised controlled trial. BMJ Open. 13(9). e058006–e058006. 2 indexed citations

Oo, Ye Htun, Lee Jenkins, Hannah C. Jeffery, et al.. (2019). Liver homing of clinical grade Tregs after therapeutic infusion in patients with autoimmune hepatitis. JHEP Reports. 1(4). 286–296. 59 indexed citations

Laing, Richard W., Hynek Mergental, Christina Yap, et al.. (2017). Viability testing and transplantation of marginal livers (VITTAL) using normothermic machine perfusion: study protocol for an open-label, non-randomised, prospective, single-arm trial. BMJ Open. 7(11). e017733–e017733. 90 indexed citations

Corrigan, Margaret, Anna Rowe, Amanda Kirkham, et al.. (2017). Investigating the safety and activity of the use of BTT1023 (Timolumab), in the treatment of patients with primary sclerosing cholangitis (BUTEO): A single-arm, two-stage, open-label, multi-centre, phase II clinical trial protocol. BMJ Open. 7(6). e015081–e015081. 24 indexed citations

Hussain, Syed A., Daniel H. Palmer, Wing‐Kin Syn, et al.. (2017). Gene expression profiling in bladder cancer identifies potential therapeutic targets. International Journal of Oncology. 50(4). 1147–1159. 21 indexed citations

King, Andrew, Darren Barton, Nwe Ni Than, et al.. (2015). REpeated AutoLogous Infusions of STem cells In Cirrhosis (REALISTIC): a multicentre, phase II, open-label, randomised controlled trial of repeated autologous infusions of granulocyte colony-stimulating factor (GCSF) mobilised CD133+ bone marrow stem cells in patients with cirrhosis. A study protocol for a randomised controlled trial. BMJ Open. 5(3). e007700–e007700. 27 indexed citations

Armstrong, Matthew J., Piers Gaunt, Guruprasad P. Aithal, et al.. (2015). Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study. The Lancet. 387(10019). 679–690. 1554 indexed citations breakdown →

10.

Gaunt, Piers, Guruprasad P. Aithal, Richard Parker, et al.. (2015). OC-016 Liraglutide is effective in the histological clearance of non-alcoholic steatohepatitis in a multicentre, double-blinded, randomised, placebo-controlled phase ii trial. A9.1–A9. 3 indexed citations

11.

Armstrong, Matthew J., Diana Hull, Kathy Guo, et al.. (2015). Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis. Journal of Hepatology. 64(2). 399–408. 351 indexed citations breakdown →

12.

James, Nicholas D., Lazaros Andronis, Ilias Goranitis, et al.. (2015). Cost-effectiveness of zoledronic acid and strontium-89 as bone protecting treatments in addition to chemotherapy in patients with metastatic castrate-refractory prostate cancer. (ISRCTN 12808747) TRAPEZE.. Journal of Clinical Oncology. 33(15_suppl). e16108–e16108. 1 indexed citations

13.

Armstrong, Matthew J., Diana Hull, Kathy Guo, et al.. (2014). Effect of liraglutide on adipose insulin resistance and hepatic de-novo lipogenesis in non-alcoholic steatohepatitis: substudy of a phase 2, randomised placebo-controlled trial. The Lancet. 383. S21–S21. 7 indexed citations

14.

Rowe, Ian, Matthew J. Armstrong, Richard Parker, et al.. (2014). Effect of scavenger receptor B-I antagonist, ITX5061, on early hepatitis C virus kinetics in liver transplantation: results of a phase 1b clinical trial. The Lancet. 383. S90–S90. 1 indexed citations

15.

Armstrong, Matthew J., D. Hull, Darren Barton, et al.. (2013). Glucagon like peptide 1 analogue, Liraglutide, reduces adipose insulin resistance and hepatic de novo lipogenesis in Nonalcoholic Steatohepatitis: Sub-study results of a phase II randomised-control clinical trial. Hepatology. 58. 1 indexed citations

16.

Armstrong, Matthew J., Darren Barton, Piers Gaunt, et al.. (2013). Liraglutide efficacy and action in non-alcoholic steatohepatitis (LEAN): study protocol for a phase II multicentre, double-blinded, randomised, controlled trial. BMJ Open. 3(11). e003995–e003995. 39 indexed citations

17.

Rowe, Ian, Matthew J. Armstrong, Richard Parker, et al.. (2013). Scavenger receptor B-I antagonist ITX5061 modulates early HCV kinetics in patients undergoing liver transplantation: results of a phase Ib clinical trial. Hepatology. 58. 1 indexed citations

18.

James, Nicholas D., Sarah Pirrie, Darren Barton, et al.. (2013). Clinical outcomes in patients with castrate-refractory prostate cancer (CRPC) metastatic to bone randomized in the factorial TRAPEZE trial to docetaxel (D) with strontium-89 (Sr89), zoledronic acid (ZA), neither, or both (ISRCTN 12808747).. Journal of Clinical Oncology. 31(18_suppl). LBA5000–LBA5000. 20 indexed citations

19.

Hull, Diana, et al.. (2012). Patient and public involvement to support liver disease research. British Journal of Nursing. 21(16). 972–976. 11 indexed citations

20.

Freimer, Nelson B., Piotr Czubkowski, Joanna Pawłowska, et al.. (2002). Clinical and biochemical features of FIC1 (ATP8B1) and BSEP (ABCB11) disease.. Hepatology. 36(4). 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact